Construction of a model cell line for the assay of MDR1 (Multi Drug Resistance gene-1) substrates/inhibitors using HeLa cells

Pharmazie

Volumn 64, Issue 5, 2009, Pages 296-300

  Kugawa, Fumihiko ^a   Suzuki, T ^b   Miyata, M ^b   Tomono, K ^b   Tamanoi, F ^c  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

^b NIHON UNIVERSITY   (Japan)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CYCLOSPORIN A; MULTIDRUG RESISTANCE PROTEIN 1; RHODAMINE 123; VERAPAMIL; VINBLASTINE; ABCB1 PROTEIN, HUMAN; FLUORESCENT DYE; GLYCOPROTEIN P;

ARTICLE; CONTROLLED STUDY; DRUG DETERMINATION; DRUG SCREENING; DRUG TRANSPORT; EUKARYOTIC CELL; EXPRESSION VECTOR; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HELA CELL; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; POLYMERASE CHAIN REACTION; WESTERN BLOTTING; BIOLOGICAL MODEL; BIOSYNTHESIS; CELL LINE; DRUG EFFECT; GENE VECTOR; GENETICS;

CELL LINE; FLUORESCENT DYES; GENETIC VECTORS; HELA CELLS; HUMANS; MODELS, GENETIC; P-GLYCOPROTEIN; RHODAMINE 123; TRANSFECTION;

EID: 70349243445     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2009.8371     Document Type: Article

References (25)

1. Chen G, Durán GE, Steger KA, Lacayo NJ, Jaffrézou JP, Dumontet C, Sikic BI (1997) Multidrug-resistant human sarcoma cells with a mutant P-glycoprotein, altered phenotype, and resistance to cyclosporines. J Biol Chem 272: 5974-5982.
2. Ernest S, Bello-Reuss E (1996) Xenobiotic transport differences in mouse mesangial cell clones expressing mdr1 and mdr3. Am J Physiol 270: C910-C919.
3. Goldberg H, Ling V, Wong PY, Skorecki K (1988) Reduced cyclosporin accumulation in multidrug-resistant cells. Biochem Biophys Res Commun 152: 552-558.
4. Gottesman MM (1993) How cancer cells evade chemotherapy: sixteen Richard and Hinda Rosenthal Foundation Award Lecture. Cancer Res 53: 747-754.
5. Gottesman MM, Pastan I (1993) Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 62: 385-427.
6. Gros P, Ben Neriah YB, Croop JM, Houseman DE (1986) Isolation and expression of a complementary DNA that confers multidrug resistance. Nature 323: 728-731.
7. Hao XY, Widersten M, Ridderström M, Hellman U, Mannervik B (1994) Co-variation of glutathione transferase expression and cytostatic drug resistance in HeLa cells: establishment of class μ glutathione transferase M3-3 as the dominating isoenzyme. Biochem J 297: 59-67.
8. Hirsch-Ernest KI, Ziemann C, Rustenbeck I, Kahl GF (2001) Inhibitors of mdr1-dependent transport activity delay accumulation of the mdr1 substrate rhodamine 123 in primary rat hepatocyte cultures. Toxicology 167: 47-57.
9. Horio M, Gottesman MM, Pastan I (1988) ATP-dependent transport of vinblastine in vesicles from human multidrug-resistant cells. Proc Natl Acad Sci USA 85: 3580-3584.
10. Horio M, Chin KV, Currier SJ, Goldenberg S, Williams C, Pastan I, Gottesman MM, Handler J (1989) Transepithelial transport of drug by the multidrug transporter in cultured madin-darby canine kidney cell epithelia. J Biol Chem 264: 14880-14884.
11. Horio M, Lovelance E, Pastan I, Gottesman MM (1991) Agents which reverse multidrug-resistance are inhibitors of [3H] vinblastin transport by isolated vesicles. Biochim Biophys Acta 1061: 106-110.
12. Kioka N, Tsubota J, Kakehi Y, Komano T, Gottesman MM, Pastan I, Ueda K (1989) P-glycoprotein gene (MDR1) cDNA from human adrenal: normal P-glycoprotein carries Gly185 with an altered pattern of multidrug resistance. Biochem Biophys Res Commun 162: 224-231.
13. Kugawa F, Aoki M (2007) Drug transporters and apoptosis. Pharmacoanesthesiology 19: 52-62. (manuscript in Japanese)
14. Kugawa F, Watanabe M, Tamanoi F (2007) Chemical biology/chemical genetics/chemical genomics: importance of chemical library. CBI Journal 7: 49-68.
15. Kuzmich S, Tew KD (1991) Detoxification mechanisms and tumor cell resistance to anticancer drugs. Med Res Rev 11: 185-217.
16. Lelong IH, Guzikowski AP, Haugland RP, Pastan I, Gottesman MM, Willingham MC (1991) Fluorescent verapamil derivative for monitoring activity of the multidrug transporter. Mol Pharmacol 40: 490-494.
17. Marzolini C, Paus E, Buclin T, Kim RB (2004) Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance. Clin Pharmacol Ther 75: 13-33.
18. Matsuzaki J, Yamamoto C, Miyama T, Takanaga H, Matsuo H, Ishizuka H, Kawahara Y, Kuwano M, Naito M, Tsuruo T, Sawada Y (1999) Contribution of P-glycoprotein to bunitrolol efflux across blood-brain barrier. Biopharm Drug Dispos 20: 85-90.
19. Noonan KE, Beck C, Holzmayer TA, Chin JE, Wunder JS, Andrulis IL, Gazdar AF, Willman CL, Griffith B, Von Hoff DD, Roninson IB (1990) Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Proc Natl Acad Sci USA 87: 7160-7164.
20. Renes J, de Vries EG, Nienhuis EF, Jansen PL, Müller M (1999) ATP- and glutathione-dependent transport of chemotherapeutic drugs by the multidrug resistance protein MRP1. Br J Pharmacol 126: 681-688.
21. Roninson IB (1992) The role of the MDR1 (P-glycoprotein) gene in multidrug resistance in vitro and in vivo. Biochem Pharmacol 43: 95-102.
22. Ueda K, Okamura N, Hirai M, Tanigawara Y, Saeki T, Kioka N, Komano T, Hori R (1992) Human P-glycoprotein transports cortisol, aldosterone, and dexamethasone, but not progesterone. J Biol Chem 267: 24248-24252.
23. Ushigome F, Koyabu N, Satoh S, Tsukimori K, Nakano H, Nakamura T, Uchiumi T, Kuwano M, Ohtani H, Sawada Y (2003) Kinetic analysis of P-glycoprotein- mediated transport by using normal human placental brush-border membrane vesicles. Pharm Res 20: 38-44.
24. Woodahl EL, Yang Z, Bui T, Shen DD, Ho RJ (2004) Multidrug resistance gene G1199A polymorphism alters efflux transport activity of P-glycoprotein. J Pharmacol Exp Ther 310: 1199-1207.
25. Yuen AR, Sikic BI (1994) Multidrug resistance in lymphomas. J Clin Oncol 12: 2453-2459.